These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 723001)

  • 1. Pharmacological studies on experimental nephritic rats. (4) Improvement of hyperlipemic models in rats utilizing anti-rat kidney rabbit serum and effects of anti-hyperlipemic agents on serum lipid levels.
    Suzuki Y; Honda Y; Ito M
    Jpn J Pharmacol; 1978 Oct; 28(5):729-38. PubMed ID: 723001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of combined treatment with niacin and chromium (III) chloride on the different tissues of hyperlipemic rats.
    Atac IA; Peksel A; Yanardag R; Sokmen BB; Doger MM; Bilen ZG
    Drug Chem Toxicol; 2006; 29(4):363-77. PubMed ID: 16931439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of benzodioxane, chroman and dihydrobenzofuran analogs of clofibrate in a Triton hyperlipemic rat model.
    Newman HA; Heilman WP; Witiak DT
    Lipids; 1973 Jul; 8(7):378-84. PubMed ID: 4724016
    [No Abstract]   [Full Text] [Related]  

  • 4. Lipid lowering activity of Phyllanthus niruri in hyperlipemic rats.
    Khanna AK; Rizvi F; Chander R
    J Ethnopharmacol; 2002 Sep; 82(1):19-22. PubMed ID: 12169400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of ciprofibrate and fenofibrate on liver lipids and lipoprotein synthesis in normo- and hyperlipidemic rats.
    Petit D; Bonnefis MT; Rey C; Infante R
    Atherosclerosis; 1988 Dec; 74(3):215-25. PubMed ID: 3240333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fundamental studies on physiological and pharmacological actions of L-ascorbate 2-sulfate. I. On the hypolipidemic effects.
    Hayashi E; Yamada J; Kunitomo M; Terada M; Tomita T; Kinoshita
    J Nutr Sci Vitaminol (Tokyo); 1976; 22(3):201-8. PubMed ID: 966076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the lipid-lowering activity of AY-25,712 in rats.
    Cayen MN; Kallai-Sanfacon MA; Dubuc J; Greselin E; Dvornik D
    Atherosclerosis; 1982 Dec; 45(3):267-79. PubMed ID: 6818976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of royal jelly on serum lipids in experimental animals and humans with atherosclerosis.
    Vittek J
    Experientia; 1995 Sep; 51(9-10):927-35. PubMed ID: 7556573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma lipoproteins and cholesterol metabolism in spontaneously hyperlipemic rats.
    Fantappiè S; Crestani M; Bosisio E; Galli G; Maggi FM; Corsini A; Catapano AL
    Atherosclerosis; 1989 Apr; 76(2-3):163-71. PubMed ID: 2730713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antioxidant activity of Tartary buckwheat bran extract and its effect on the lipid profile of hyperlipidemic rats.
    Wang M; Liu JR; Gao JM; Parry JW; Wei YM
    J Agric Food Chem; 2009 Jun; 57(11):5106-12. PubMed ID: 19419146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACTH lowers serum lipids in steroid-treated hyperlipemic patients with kidney disease.
    Berg AL; Nilsson-Ehle P
    Kidney Int; 1996 Aug; 50(2):538-42. PubMed ID: 8840283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of hypolipidemic activity of leaf juice of Catharanthus roseus (Linn.) G. Donn. in guinea pigs.
    Patel Y; Vadgama V; Baxi S; Chandrabhanu ; Tripathi B
    Acta Pol Pharm; 2011; 68(6):927-35. PubMed ID: 22125959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of KC-9432, a new hypolipidemic compound, on high density lipoprotein cholesterol in rats.
    Seri K; Sato R; Hamazaki Y; Yamamoto T; Ishiyama N
    Atherosclerosis; 1980 Sep; 37(1):97-102. PubMed ID: 6893550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyenylphosphatidylcholine decreases alcoholic hyperlipemia without affecting the alcohol-induced rise of HDL-cholesterol.
    Navder KP; Baraona E; Lieber CS
    Life Sci; 1997; 61(19):1907-14. PubMed ID: 9364195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Variation of lipids in rats fed a cholesterol diet (author's transl)].
    Nakayama S; Sakashita M; Nishimura T; Sakamoto K
    Nihon Yakurigaku Zasshi; 1981 Aug; 78(2):91-107. PubMed ID: 7319399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The action of a fibric acid derivative on lipid metabolism].
    Filip M; Păduraru I; Nechifor M; Dănilă GH; Popovici I; Filip FM; Poşircă F
    Rev Med Chir Soc Med Nat Iasi; 1989; 93(3):573-6. PubMed ID: 2636755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effects of combined treatment with niacin and chromium on the liver of hyperlipemic rats.
    Bolkent S; Yanardag R; Bolkent S; Döger MM
    Biol Trace Elem Res; 2004 Dec; 101(3):219-29. PubMed ID: 15564652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental hyper-beta-lipoproteinemia and its amelioration by a novel hypolipidemic agent.
    Kobayakawa T; Osuga K; Yasuda H
    Atherosclerosis; 1978 Jul; 30(3):219-25. PubMed ID: 209804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypolipidemic activity of Achyranthus aspera Linn in normal and triton induced hyperlipemic rats.
    Khanna AK; Chander R; Singh C; Srivastava AK; Kapoor NK
    Indian J Exp Biol; 1992 Feb; 30(2):128-30. PubMed ID: 1521862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accumulation and loss of cholesterol esters in monkey arterial smooth muscle cells exposed to normal and hyperlipemic serum lipoproteins.
    Bates SR
    Atherosclerosis; 1979 Feb; 32(2):165-76. PubMed ID: 222304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.